Work

A Phase 1/11 trial of IV CG7870, a replication-selective, PSA-targeted oncolytic adenovirus (OAV), for the treatment of hormone-refractory, metastatic prostate cancer

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3036

Authors: G. Wilding, M. Carducci, D. C. Yu, J. Burke, F. Borellini, J. Aimi, P. Working, D. Ando, D. Kirn, E. Small

Institutions: University of Wisconsin–Madison, Johns Hopkins University, University of California, San Francisco

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601451002

Cites:

Cited by: 4

Related to: 10